The Association between Quality of Care and the Intensity of Diabetes Disease Management Programs

  1. Carol M. Mangione, MD, MSPH;
  2. Robert B. Gerzoff, MS;
  3. David F. Williamson, PhD;
  4. W. Neil Steers, PhD;
  5. Eve A. Kerr, MD;
  6. Arleen F. Brown, MD, PhD;
  7. Beth E. Waitzfelder, PhD;
  8. David G. Marrero, PhD;
  9. R. Adams Dudley, MD, MBA;
  10. Catherine Kim, MD, MPH;
  11. William Herman, MD;
  12. Theodore J. Thompson, MS;
  13. Monika M. Safford, MD;
  14. Joe V. Selby, MD, MPH; and
  15. for the TRIAD Study Group*
  1. From David Geffen School of Medicine at UCLA, Los Angeles, California; Centers for Disease Control and Prevention, Atlanta, Georgia; Veterans Affairs Ann Arbor Healthcare System and University of Michigan Medical School, Ann Arbor, Michigan; University of Medicine and Dentistry of New Jersey, Newark, New Jersey; Pacific Health Research Institute, Honolulu, Hawaii; Indiana University School of Medicine, Indianapolis, Indiana; Institute for Health Policy Studies, University of California–San Francisco, San Francisco, California; and Kaiser Permanente, Oakland, California.
    1. Figure. *Patients receiving care in one of the Translating Research into Action for Diabetes (TRIAD) study health plans and whose diabetes diagnosis was based on the following criteria: a diagnostic code for diabetes (for example, 2 or more outpatient visits with International Classification of Diseases, Ninth Revision, code 250. ) or 1 or more inpatient stays with an associated diabetes code; results of laboratory studies suggestive of diabetes (for example, 2 or more hemoglobin A tests or diagnostic levels of hemoglobin A or fasting blood glucose); or a prescription for medications for diabetes (for example, insulin or an oral antidiabetic agent). †At the time of the survey, patients who met the initial criteria were included only if they verified that they had diabetes and received most of their diabetes care through the participating TRIAD health plan. ‡Participants cared for under direct contracting agreements with health plans rather than in physician groups were assigned a value of 0 for each care management strategy at the physician group level.
      View larger version:
        Figure. *Patients receiving care in one of the Translating Research into Action for Diabetes (TRIAD) study health plans and whose diabetes diagnosis was based on the following criteria: a diagnostic code for diabetes (for example, 2 or more outpatient visits with International Classification of Diseases, Ninth Revision, code 250. ) or 1 or more inpatient stays with an associated diabetes code; results of laboratory studies suggestive of diabetes (for example, 2 or more hemoglobin A tests or diagnostic levels of hemoglobin A or fasting blood glucose); or a prescription for medications for diabetes (for example, insulin or an oral antidiabetic agent). †At the time of the survey, patients who met the initial criteria were included only if they verified that they had diabetes and received most of their diabetes care through the participating TRIAD health plan. ‡Participants cared for under direct contracting agreements with health plans rather than in physician groups were assigned a value of 0 for each care management strategy at the physician group level. Description of sampling and response rate.xx1c1c

      Summary for Patients

      • Summaries for Patients:Relationship of Intensity of Diabetes Disease Management Programs and Quality of Care Ann Intern Med July 18, 2006 145:I-41
      « Previous | Next Article »Table of Contents

      This Article

      1. Ann Intern Med July 18, 2006 vol. 145 no. 2 107-116
      1. AbstractFREE
      2. » Figures
      3. Full Text
      4. Full Text (PDF)
        1. Summary for Patients
      6. Appendix Figure

      Rapid Responses

      1. Submit a response
      2. No responses published

      Current Issue

      1. November 17, 2009, 151 (10)
      1. Alert me to current issues